机构:[1]State Key Laboratory of Organ Failure Research, MOE Key Laboratory of Infectious Diseases Research in South China, Guangdong Provincial Key Laboratory for Prevention and Control of Major Liver Diseases, Guangdong Institute of Liver Diseases, Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, Guangzhou, China.[2]The Key Laboratory of Molecular Pathology in Tumors of Guangxi Higher Education Institutions, Department of Pathology, the Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.[3]Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu, China.四川大学华西医院[4]Precision Regenerative Medicine Research Centre, Medical Science Division, and State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macao, China.
the National Key
Research and Development Program of China (No.
2022YFC2303600 to D.K.J.), the General Programs from
the National Natural Science Foundation of China (No.
82272765 to D.K.J.), the Guangdong Basic and Applied Basic
Research Foundation (No. 2022A1515220090 to D.K.J.), the
Local Innovative and Research Teams Project of Guangdong
Pearl River Talents Program (No. 2017BT01S131 to D.K.J.),
the Innovative Research Team Project of Guangxi Province
(No. 2017GXNSFGA198002 to D.K.J.), the Grant for
Recruited Talents to Start Scientific Research from Nanfang
Hospital, and the Outstanding Youth Development Scheme
of Nanfang Hospital, Southern Medical University (No.
2017J001 to D.K.J.).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类|4 区医学
小类|4 区胃肠肝病学
最新[2025]版:
大类|4 区医学
小类|4 区胃肠肝病学
第一作者:
第一作者机构:[1]State Key Laboratory of Organ Failure Research, MOE Key Laboratory of Infectious Diseases Research in South China, Guangdong Provincial Key Laboratory for Prevention and Control of Major Liver Diseases, Guangdong Institute of Liver Diseases, Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, Guangzhou, China.[2]The Key Laboratory of Molecular Pathology in Tumors of Guangxi Higher Education Institutions, Department of Pathology, the Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
共同第一作者:
通讯作者:
通讯机构:[1]State Key Laboratory of Organ Failure Research, MOE Key Laboratory of Infectious Diseases Research in South China, Guangdong Provincial Key Laboratory for Prevention and Control of Major Liver Diseases, Guangdong Institute of Liver Diseases, Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, Guangzhou, China.[2]The Key Laboratory of Molecular Pathology in Tumors of Guangxi Higher Education Institutions, Department of Pathology, the Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
推荐引用方式(GB/T 7714):
Zou Hongjie,Liang Xinghe,Luo Mengqi,et al.Causal effects of immune cell phenotypes on the risk of autoimmune liver diseases: a bidirectional two-sample Mendelian randomization study[J].Translational Gastroenterology And Hepatology.2025,10:68.doi:10.21037/tgh-25-2.
APA:
Zou Hongjie,Liang Xinghe,Luo Mengqi,Pan Xinghua&Jiang De-Ke.(2025).Causal effects of immune cell phenotypes on the risk of autoimmune liver diseases: a bidirectional two-sample Mendelian randomization study.Translational Gastroenterology And Hepatology,10,
MLA:
Zou Hongjie,et al."Causal effects of immune cell phenotypes on the risk of autoimmune liver diseases: a bidirectional two-sample Mendelian randomization study".Translational Gastroenterology And Hepatology 10.(2025):68